Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Biohaven Pharmaceutical Holding Co Ltd. (BHVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/14/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
10/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 CHILDS JOHN W (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 3,025,001 shares @ $148.5, valued at $449.2M
Disposed/sold 10,000 shares @ $148.5, valued at $1.5M
Disposed/sold 8,239 options to buy @ $0
Disposed/sold 11,996 options to buy @ $0
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 3,320 options to buy @ $0
Disposed/sold 8,239 options to buy @ $0
Disposed/sold 11,996 options to buy @ $0
Disposed/sold 26,200 options to buy @ $0
10/03/2022 4 GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 8,239 options to buy @ $0
Disposed/sold 11,996 options to buy @ $0
Disposed/sold 18,000 options to buy @ $0
10/03/2022 4 JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 14,226 shares @ $148.5, valued at $2.1M
Disposed/sold 11,250 options to buy @ $0
Disposed/sold 10,000 options to buy @ $0
Disposed/sold 3,000 options to buy @ $0
Disposed/sold 775 options to buy @ $0
Disposed/sold 29,225 options to buy @ $0
Disposed/sold 2,398 options to buy @ $0
Disposed/sold 37,602 options to buy @ $0
Disposed/sold 1,742 options to buy @ $0
Disposed/sold 28,258 options to buy @ $0
Disposed/sold 5,913 options to buy @ $0
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 HUGIN ROBERT J (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 2,900 shares @ $148.5, valued at $430.7k
Disposed/sold 3,417 options to buy @ $0
Disposed/sold 8,239 options to buy @ $0
Disposed/sold 11,996 options to buy @ $0
Disposed/sold 18,948 options to buy @ $0
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns: Disposed/sold 2,583,658 shares @ $148.5, valued at $383.7M
Disposed/sold 8,239 options to buy @ $0
Disposed/sold 11,996 options to buy @ $0
Disposed/sold 18,000 options to buy @ $0
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 8-K Quarterly results
10/03/2022 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
10/03/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/03/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/03/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/03/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/29/2022 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
09/28/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
09/23/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
09/23/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/23/2022 8-K Other Events  Interactive Data
09/19/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Appendix A [Omitted.&#93"
09/19/2022 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]:
09/19/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Biohaven Announces Record Date for Anticipated Spin-Off"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy